Dan is a partner in Reed Smith’s Commercial Litigation Group, with responsibility for handling a wide range of complex commercial litigation matters in state and federal courts around the country. He also has substantial experience arbitrating commercial disputes, which includes the enforcement of arbitral agreements and awards. In addition, Dan has considerable experience managing the complete electronic discovery process, in the context of both litigation and arbitration.

During his years of practice, Dan has developed particular experience representing clients in the life-sciences industry that have been faced with commercial and contractual litigation, product liability matters, and toxic-exposure cases. As a result, Dan has a wealth of knowledge regarding both the business and litigation issues that today’s dynamic life sciences and pharmaceutical companies are apt to encounter. His experience is cross-disciplinary and extends to the transactional, regulatory and intellectual property issues that are essential to understanding the specialized needs of life sciences companies confronted with complex litigation. Dan is familiar with many of the issues associated with the life cycle of prescription and over-the-counter products manufactured by both branded and generic pharmaceutical companies, including pre-clinical and clinical development, NDA and ANDA regulatory approval, successful launch and commercialization, and product licensing, supply, collaboration and promotion.

In addition to his specialized life sciences experience, Dan has defended a number of personal injury and wrongful death actions arising out of allegations of workplace chemical exposure or allegedly defective consumer products, swimming pools and heavy equipment/machinery.